Piotr Radojewski

Piotr Radojewski

Auto-generated profile, based on publicly available information

Piotr Radojewski

Support Center for Advanced Neuroimaging, Institute for Diagnostic and Interventional Neuroradiology, University of Bern

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2024 in Neurology
Verified
Journal Article
Open access
MGMartina B. Goeldlin
Martina B. Goeldlin
MMMadlaine Müller
Madlaine Müller
BSBernhard M. Siepen
Bernhard M. Siepen
WZWenpeng Zhang
Wenpeng Zhang
HOHatice Ozkan
Hatice Ozkan
FIfor Swiss Stroke Registry Investigators and SIGNAL Investigators
for Swiss Stroke Registry Investigators and SIGNAL Investigators
Cerebral small vessel disease (SVD) is the major cause of intracerebral hemorrhage (ICH). There is no comprehensive, easily applicable classification of ICH subtypes according to the presumed underlying SVD using MRI. We developed an MRI-based classification for SVD-related ICH. We performed a retrospective study in the prospectively collected Swiss Stroke Registry (SSR, 2013-2019) and the Stroke InvestiGation in North And central London (SIGNAL) cohort. Patients with nontraumatic, SVD-related ICH and available MRI within 3 months were classified as Cerebral Amyloid angiopathy (CAA), Deep perforator arteriopathy (DPA), Mixed CAA-DPA, or Undetermined SVD using hemorrhagic and nonhemorrhagic MRI markers (CADMUS classification). The primary outcome was inter-rater reliability using Gwet's AC1. Secondary outcomes were recurrent ICH/ischemic stroke at 3 months according to the CADMUS phenotype. We performed Firth penalized logistic regressions and competing risk analyses. The SSR cohort included 1,180 patients (median age [interquartile range] 73 [62-80] years, baseline NIH Stroke Scale 6 [2-12], 45.6% lobar hematoma, systolic blood pressure on admission 166 [145-185] mm Hg). The CADMUS phenotypes were as follows: mixed CAA-DPA (n = 751 patients, 63.6%), undetermined SVD (n = 203, 17.2%), CAA (n = 154, 13.1%), and DPA (n = 72, 6.3%), with a similar distribution in the SIGNAL cohort (n = 313). Inter-rater reliability was good (Gwet's AC1 for SSR/SIGNAL 0.69/0.74). During follow-up, 56 patients had 57 events (28 ICH, 29 ischemic strokes). Three-month event rates were comparable between the CADMUS phenotypes. CADMUS, a novel MRI-based classification for SVD-associated ICH, is feasible and reproducible and may improve the classification of ICH subtypes in clinical practice and research.

28 October 2021 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
PRP. Radojewski
P. Radojewski
JSJ. Slotboom
J. Slotboom
AJA. Joseph
A. Joseph
RWR. Wiest
R. Wiest
PMP. Mordasini
P. Mordasini
SUMMARY: Most unruptured intracranial aneurysms can be adequately characterized using 1.5T and 3T MR imaging. Findings in a subgroup of patients can remain unclear due to difficulties in distinguishing aneurysms from vascular anatomic variants. We retrospectively analyzed clinical data from 30 patients with suspected incidental aneurysms on 3T MR imaging who underwent 7T MR imaging. In all 30 cases, the differentiation of an aneurysm versus a vascular variant could be achieved. In 20 cases (66%), the initial suspected diagnosis was revised. Our findings suggest that 7T MR imaging provides a clarification tool for the group of patients with suspected unruptured intracranial aneurysms and diagnostic ambiguity after standard 3T MR imaging.

26 February 2022 in NeuroImage: Clinical
Verified
Journal Article
Open access
SAStephanie Abgottspon
Stephanie Abgottspon
RMRaphaela Muri
Raphaela Muri
SCShawn E. Christ
Shawn E. Christ
MHMichel Hochuli
Michel Hochuli
PRPiotr Radojewski
Piotr Radojewski
RERegula Everts
Regula Everts
Phenylketonuria (PKU) is an inborn error of metabolism affecting the conversion of phenylalanine (Phe) into tyrosine. Previous research has found cognitive and functional brain alterations in individuals with PKU even if treated early. However, little is known about working memory processing and its association with task performance and metabolic parameters. The aim of the present study was to examine neural correlates of working memory and its association with metabolic parameters in early-treated adults with PKU. This cross-sectional study included 20 early-treated adults with PKU (mean age: 31.4 years ± 9.0) and 40 healthy controls with comparable age, sex, and education (mean age: 29.8 years ± 8.2). All participants underwent functional magnetic resonance imaging (fMRI) of working memory to evaluate the fronto-parietal working memory network. Fasting blood samples were collected from the individuals with PKU to acquire a concurrent plasma amino acid profile, and retrospective Phe concentrations were obtained to estimate an index of dietary control. On a cognitive level, early-treated adults with PKU displayed significantly lower accuracy but comparable reaction time in the working memory task compared to the control group. Whole-brain analyses did not reveal differences in working memory-related neural activation between the groups. Exploratory region-of-interest (ROI) analyses indicated reduced neural activation in the left and right middle frontal gyri and the right superior frontal gyrus in the PKU group compared to the control group. However, none of the ROI analyses survived correction for multiple comparisons. Neural activation was related to concurrent Phe, tyrosine, and tryptophan concentrations but not to retrospective Phe concentrations. In early-treated adults with PKU, cognitive performance and neural activation are slightly altered, a result that is partly related to metabolic parameters. This study offers a rare insight into the complex interplay between metabolic parameters, neural activation, and cognitive performance in a sample of individuals with PKU.

15 December 2024 in European Journal of Neurology
Verified
Journal Article
Open access
PRPiotr Radojewski
Piotr Radojewski
GPGian Franco Piredda
Gian Franco Piredda
GBGabriele Bonanno
Gabriele Bonanno
KLKarl‐Olof Lövblad
Karl‐Olof Lövblad
MVMaria Isabel Vargas
Maria Isabel Vargas
RWRoland Wiest
Roland Wiest
Background: Ultra‐high‐field magnetic resonance imaging (MRI) at a field strength of 7 Tesla (T) has marked a significant milestone in diagnostic imaging since it was approved for clinical use in 2017. Despite the potential to improve image analysis by advances in signal‐to‐noise ratio, and improved spatial resolution and metabolic imaging, the clinical implementation of 7‐T MRI remains limited. Factors that contribute to this limited availability are the high price, the operating costs, the need for specifically educated personnel, and lack of evidence of clinical benefit.Methods: The aim of this scoping review was to evaluate the evidence of the clinical advantages of 7‐T MRI versus MRI at lower field strengths, complementary imaging modalities, and diagnostic standard approaches for neurological and musculoskeletal disorders. We searched MEDLINE, CENTRAL, Embase and Web of Science for this review.Results: We identified 1966 studies, of which 83 were included in our review. Most studies (73 studies, 88%) examined neurological indications, nine studies (11%) examined musculoskeletal indications, and one study reported on peripheral arterial occlusive disease. Of the neuroimaging indications, cerebrovascular diseases were the most frequently investigated (14 studies), followed by multiple sclerosis (13 studies) and epilepsy (11 studies).Conclusion: The available comparative evidence varied greatly across indications, with the best‐documented evidence being for imaging of epilepsy. Risk of bias overall was high, with limitations in blinding information, study design reporting, and patient recruitment details. The identified evidence gaps underscore the need for comparative research to determine appropriate indications and to understand whether the potential diagnostic advantage of 7‐T MRI translates to a tangible clinical benefit for patients. Future studies should include clinically relevant patient outcomes that go beyond radiological metrics.

7 December 2022 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
GPGian Franco Piredda
Gian Franco Piredda
SCSamuele Caneschi
Samuele Caneschi
THTom Hilbert
Tom Hilbert
GBGabriele Bonanno
Gabriele Bonanno
AJArun Joseph
Arun Joseph
PRPiotr Radojewski
Piotr Radojewski

31 March 2023 in Clinical Neuroradiology
Verified
Journal Article
Open access
PDF file
PRPiotr Radojewski
Piotr Radojewski
TDTomas Dobrocky
Tomas Dobrocky
MBMattia Branca
Mattia Branca
WAWilliam Almiri
William Almiri
MCManuel Correia
Manuel Correia
PMPasquale Mordasini
Pasquale Mordasini
Purpose: Differentiating normal anatomical variants such as an infundibulum or a vascular loop from true intracranial aneurysms is crucial for patient management. We hypothesize that high-resolution 7 T magnetic resonance imaging (MRI) improves the detection and characterization of normal anatomical variants that may otherwise be misdiagnosed as small unruptured aneurysms. Methods: This is a retrospective, single-center study. All patients were scanned on a clinically approved 7 T MRI scanner and on a 3 T scanner. Image analysis was performed independently by three neuroradiologists blinded to clinical information. The presence of an unruptured intracranial aneurysm (UIA) and level of diagnostic certainty were assessed and the interrater agreement was calculated. If an aneurysm was present, the anatomic location and shape were recorded and compared. Results: In total, 53 patients with equivocal cerebrovascular findings on 1.5 T or 3 T MRI referred for a 7T MRI examination were included. Aneurysms were suspected in 42 patients examined at 3 T and in 23 patients at 7 T (rate difference 36%, 95% confidence interval, CI, 19–53%, p-value < 0.001). Major disagreement between the field strengths was observed in the A1 segment of anterior cerebral artery/anterior communicating artery (A1/ACOM) complex. The interrater agreement among the readers on the presence of an aneurysm on 7 T MRI was higher than that for 3 T MRI (0.925, 95% CI 0.866–0.983 vs. 0.786, 95% CI 0.700–0.873). Conclusion: Our analysis demonstrates a significantly higher interrater agreement and improved diagnostic certainty when small intracranial aneurysms are visualized on 7 T MRI compared to 3 T. In a selected patient cohort, clinical implementation of 7 T MRI may help to establish the definitive diagnosis and thus have a beneficial impact on patient management.